CANARY biosensor reaction

CANARY Technology

A novel biosensor with unprecedented performance

CANARY® (Cellular Analysis and Notification of Antigen Risks and Yields) is a cell-based biosensor technology that delivers extremely rapid detection of pathogens at previously unseen levels of sensitivity and specificity.

Developed by the scientists at MIT-Lincoln Laboratories, CANARY® incorporates pathogen-specific antibodies expressed on the biosensor surface which, in the presence of a pathogen (virus, bacteria or toxin), trigger an intracellular calcium release that in turn activates bioluminescent proteins whose light output can be measured and analyzed.